Oral report | The positive interim analysis results from the Phase III clinical study of Akeso's Cadonilimab (PD-1/CTLA-4 BsAb) plus chemotherapy as first-line treatment for advanced gastric cancer presented at 2024 AACR

SAN DIEGO, April 9, 2024 /PRNewswire/ — Akeso, Inc. (9926.HK) today announced…

Nano Labs Files Annual Report on Form 20-F for Fiscal Year 2023

HANGZHOU, China, April 9, 2024 /PRNewswire/ — Nano Labs Ltd (Nasdaq: NA)…

PENSKE AUTOMOTIVE GROUP TO EXPAND RETAIL AUTOMOTIVE PRESENCE INTO AUSTRALIA

BLOOMFIELD HILLS, Mich., April 9, 2024 /PRNewswire/ — Penske Automotive Group, Inc.…

TraceLink Named a Leader in IDC MarketScape: Worldwide Multi-Enterprise Supply Chain Commerce Network Vendor Assessment

BOSTON, April 9, 2024 /PRNewswire/ — TraceLink Inc. has been named a…

Anycubic Unveils 2024 Strategy to Refine 3D Printing Experience

SHENZHEN, China, April 9, 2024 /PRNewswire/ — On April 8, 2024, Anycubic unveiled a…

VRITIMES Partners with Technophile to Deliver Cutting-Edge Press Release Coverage

Manila, April 8, 2024 – VRITIMES, a leading media company known for its…

STRADVISION Enhances Automated Driving Solution with Next-Gen SVNet on Horizon Robotics Journey™ 3

SEOUL, South Korea, April 8, 2024 /PRNewswire/ — Expanding on their strategic…

The first press conference with cats was held in Colombia

To present the first Casa de Adopción de Amores Imposibles [House of…